Last update 01 Nov 2024

CDH17-positive Solid Tumor

Basic Info

Synonyms-
Introduction-

Related

1
Drugs associated with CDH17-positive Solid Tumor
Anti-CDH17 CAR-T Cell(UTC Therapeutics)
Target
CDH17
Mechanism
CDH17 antagonists
Active Org.
UTC Therapeutics (Shanghai) Co., Ltd.UTC Therapeutics (Shanghai) Co., Ltd.
Originator Org.
UTC Therapeutics (Shanghai) Co., Ltd.UTC Therapeutics (Shanghai) Co., Ltd.
Active Indication
CDH17-positive Solid Tumor
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with CDH17-positive Solid Tumor
NCT06501183 / RecruitingPhase 1IIT
Exploratory Study to Evaluate the Safety and Preliminary Efficacy of Anti-CDH17 CAR-T Cell Injection in Patients With CDH17-positive Advanced Malignant Solid Tumors
100 Clinical Results associated with CDH17-positive Solid Tumor
Login to view more data
100 Translational Medicine associated with CDH17-positive Solid Tumor
Login to view more data
0 Patents (Medical) associated with CDH17-positive Solid Tumor
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free